Klyv Therapeutics was among a small group of Norwegian biotech companies to meet Dr N. Kalaiselvi, Director General of India’s Council of Scientific and Industrial Research (CSIR), and her delegation during a visit to Forskningsparken – Oslo Science Park. Klyv’s COO Hanne Th. Bonge-Hansen took part in the discussions, alongside representatives from other companies based at the park.
The visit brought together Indian and Norwegian drug developers for an open exchange on how the two countries’ life science communities can learn from and support one another. For an early-stage company like Klyv, conversations like these are a valuable way to build relationships and share experience across borders.